- Global Pharma News & Resources

Small Molecule API Market will grow at 9.1% CAGR, was valued at US$ 126.6 billion in 2020 | Global Industry Analysis by Company Profiles, Segments, Size, Landscape and Demand


A small molecule API (active pharmaceutical ingredient) is a low molecular weight organic compound used to control biological process, with a size on the order of 1 nm. Most of the small molecules can be administered orally and are most likely to be absorbed by the body. Moreover, small molecules have some considerable advantages over large molecules. This drugs includes most patented medicines on the market and their generic counterparts.

Request Here For Market Latest Insights:


Continuous research and development (R&D) by key players operating in the market, to develop novel products to meet increasing demands of patients, is expected to propel the global small molecule API market growth during the forecast period. According to the India Brand Equity Foundation (IBEF), in financial year 2018, the investments in research and development by the leading Indian pharmaceutical companies amounted to around 8.5% of their total sales. Moreover, according to the Food and Drug Administration (FDA), there were about 37 drugs in clinical development in 2016 to treat serious bacterial infections.

Furthermore, increasing prevalence of cancers across the globe is expected to augment the growth of the global small molecule API market. According to the report published the in 2018 by the International Agency for Research on Cancer, in 2018, around 18.1 million new cancer cases were diagnosed and around 9.6 million people died from the disease.


Market player are adopting various growth strategies, such as mergers and acquisitions, to enhance their market presence. For example, CordenPharma entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer, Inc. in October 2017.

Purchase this Report at Discount Of US $2000 Flat OFF –

Major Players:

Major players active in the small molecule API market include Faran Shimi Pharmaceutical Co, Micro Orgo Chem, Rusan Pharma, Resonance-labs, Arevipharma GmbH, Unichem Laboratories, Noramco, Mallinckrodt, Johnson Matthey, Sanofi, Siegfried, and Sun Pharmaceutical Ltd.

Table of Content

Global Small Molecule API Market Research Report
Section 1: Global Small Molecule API Industry Overview
Section 2: Global Economic Impact on Small Molecule API Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Small Molecule API Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Small Molecule API Market Forecast

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 22-Sep-2021